Coeptis Therapeutics Inc (COEP) — Strategic Asset Allocation Index
Coeptis Therapeutics Inc (COEP) has a Strategic Asset Allocation Index of 53.3% as of September 2025. Strategic assets (PP&E of $- plus long-term investments of $6.94 Million) total $6.94 Million, measured against net assets of $13.02 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See how leveraged is Coeptis Therapeutics Inc's balance sheet to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Coeptis Therapeutics Inc Strategic Asset Allocation Index (2018–2024)
This chart shows how Coeptis Therapeutics Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2024. As of September 2025, the index stands at 53.3%, representing strategic assets of $6.94 Million against net assets of $13.02 Million USD. For live market cap and overall valuation, see COEP company net worth.
Annual Strategic Asset Allocation Index for Coeptis Therapeutics Inc (2018–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for Coeptis Therapeutics Inc from 2018 to 2024, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See COEP net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 147.2% | $5.69 Million | $- | $5.69 Million | $3.87 Million | ▲ +147.2 pp |
| 2023 | 0.0% | $0.00 | $- | $0.00 | $4.45 Million | ▼ -1.4 pp |
| 2021 | 1.4% | $31.85K | $31.85K | $- | $2.35 Million | ▼ -693.4 pp |
| 2019 | 694.8% | $109.03K | $109.03K | $- | $15.69K | ▲ +583.7 pp |
| 2018 | 111.1% | $19.91K | $19.91K | $- | $17.93K | — |